4-119501236-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001083.4(PDE5A):c.2424G>A(p.Glu808=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00169 in 1,607,706 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0092 ( 19 hom., cov: 32)
Exomes 𝑓: 0.00091 ( 16 hom. )
Consequence
PDE5A
NM_001083.4 synonymous
NM_001083.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.42
Genes affected
PDE5A (HGNC:8784): (phosphodiesterase 5A) This gene encodes a cGMP-binding, cGMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family. This phosphodiesterase specifically hydrolyzes cGMP to 5'-GMP. It is involved in the regulation of intracellular concentrations of cyclic nucleotides and is important for smooth muscle relaxation in the cardiovascular system. Alternative splicing of this gene results in three transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 4-119501236-C-T is Benign according to our data. Variant chr4-119501236-C-T is described in ClinVar as [Benign]. Clinvar id is 786047.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.41 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00917 (1396/152234) while in subpopulation AFR AF= 0.0319 (1324/41546). AF 95% confidence interval is 0.0304. There are 19 homozygotes in gnomad4. There are 638 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 19 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDE5A | NM_001083.4 | c.2424G>A | p.Glu808= | synonymous_variant | 20/21 | ENST00000354960.8 | NP_001074.2 | |
PDE5A | NM_033430.3 | c.2298G>A | p.Glu766= | synonymous_variant | 20/21 | NP_236914.2 | ||
PDE5A | NM_033437.4 | c.2268G>A | p.Glu756= | synonymous_variant | 20/21 | NP_246273.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDE5A | ENST00000354960.8 | c.2424G>A | p.Glu808= | synonymous_variant | 20/21 | 1 | NM_001083.4 | ENSP00000347046 | ||
ENST00000688315.1 | n.1003+3333C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00912 AC: 1387AN: 152116Hom.: 18 Cov.: 32
GnomAD3 genomes
AF:
AC:
1387
AN:
152116
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00226 AC: 567AN: 250772Hom.: 5 AF XY: 0.00162 AC XY: 219AN XY: 135528
GnomAD3 exomes
AF:
AC:
567
AN:
250772
Hom.:
AF XY:
AC XY:
219
AN XY:
135528
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000912 AC: 1327AN: 1455472Hom.: 16 Cov.: 27 AF XY: 0.000780 AC XY: 565AN XY: 724638
GnomAD4 exome
AF:
AC:
1327
AN:
1455472
Hom.:
Cov.:
27
AF XY:
AC XY:
565
AN XY:
724638
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00917 AC: 1396AN: 152234Hom.: 19 Cov.: 32 AF XY: 0.00857 AC XY: 638AN XY: 74440
GnomAD4 genome
AF:
AC:
1396
AN:
152234
Hom.:
Cov.:
32
AF XY:
AC XY:
638
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 13, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at